
### [MONDO:0020271](http://purl.obolibrary.org/obo/MONDO_0020271)
**Label:** phakomatosis with eye involvement

**Subclasses:** [MONDO:0013199](http://purl.obolibrary.org/obo/MONDO_0013199) (tuberous sclerosis 2), [MONDO:0014299](http://purl.obolibrary.org/obo/MONDO_0014299) (Schwannomatosis 2), [MONDO:0018975](http://purl.obolibrary.org/obo/MONDO_0018975) (neurofibromatosis), [MONDO:0008075](http://purl.obolibrary.org/obo/MONDO_0008075) (neurofibromatosis type 3), [MONDO:0008077](http://purl.obolibrary.org/obo/MONDO_0008077) (neurofibromatosis, type 1), [MONDO:0008078](http://purl.obolibrary.org/obo/MONDO_0008078) (neurofibromatosis, familial spinal), [MONDO:0015350](http://purl.obolibrary.org/obo/MONDO_0015350) (17q11.2 microduplication syndrome), [MONDO:0019341](http://purl.obolibrary.org/obo/MONDO_0019341) (tuberous sclerosis complex), [MONDO:0008612](http://purl.obolibrary.org/obo/MONDO_0008612) (tuberous sclerosis 1), [MONDO:0007039](http://purl.obolibrary.org/obo/MONDO_0007039) (neurofibromatosis type 2), [MONDO:0013357](http://purl.obolibrary.org/obo/MONDO_0013357) (chromosome 17q11.2 deletion syndrome, 1.4Mb), [MONDO:0008080](http://purl.obolibrary.org/obo/MONDO_0008080) (neurofibromatosis, type Iii, mixed central and peripheral), [MONDO:0008081](http://purl.obolibrary.org/obo/MONDO_0008081) (neurofibromatosis, type Iv, of riccardi), [MONDO:0018208](http://purl.obolibrary.org/obo/MONDO_0018208) (neurofibromatosis type 1 due to NF1 mutation or intragenic deletion), 

**Corr. equiv. classes:** [OMIM:162200](http://purl.obolibrary.org/obo/OMIM_162200), [OMIM:162210](http://purl.obolibrary.org/obo/OMIM_162210), [Orphanet:363700](http://www.orpha.net/ORDO/Orphanet_363700), [OMIM:162260](http://purl.obolibrary.org/obo/OMIM_162260), [OMIM:191100](http://purl.obolibrary.org/obo/OMIM_191100), [OMIM:162270](http://purl.obolibrary.org/obo/OMIM_162270), [Orphanet:139474](http://www.orpha.net/ORDO/Orphanet_139474), [OMIM:162091](http://purl.obolibrary.org/obo/OMIM_162091), [OMIM:615670](http://purl.obolibrary.org/obo/OMIM_615670), [Orphanet:93921](http://www.orpha.net/ORDO/Orphanet_93921), [OMIM:613254](http://purl.obolibrary.org/obo/OMIM_613254), [Orphanet:805](http://www.orpha.net/ORDO/Orphanet_805), [OMIM:613675](http://purl.obolibrary.org/obo/OMIM_613675), [Orphanet:636](http://www.orpha.net/ORDO/Orphanet_636), [Orphanet:97685](http://www.orpha.net/ORDO/Orphanet_97685), [Orphanet:637](http://www.orpha.net/ORDO/Orphanet_637), [OMIM:101000](http://purl.obolibrary.org/obo/OMIM_101000), 

**Class expressions from DL-Learner:**

- [HP:0001067](http://purl.obolibrary.org/obo/HP_0001067) (Neurofibromas) and [HP:0004328](http://purl.obolibrary.org/obo/HP_0004328) (Abnormality of the anterior segment of the globe) and [HP:0100835](http://purl.obolibrary.org/obo/HP_0100835) (Benign neoplasm of the central nervous system) 64.71%
- [HP:0001067](http://purl.obolibrary.org/obo/HP_0001067) (Neurofibromas) and [HP:0002858](http://purl.obolibrary.org/obo/HP_0002858) (Meningioma) and [HP:0004328](http://purl.obolibrary.org/obo/HP_0004328) (Abnormality of the anterior segment of the globe) 64.71%
- [HP:0000957](http://purl.obolibrary.org/obo/HP_0000957) (Cafe-au-lait spot) and [HP:0001067](http://purl.obolibrary.org/obo/HP_0001067) (Neurofibromas) and [HP:0100835](http://purl.obolibrary.org/obo/HP_0100835) (Benign neoplasm of the central nervous system) 64.71%
- [HP:0000957](http://purl.obolibrary.org/obo/HP_0000957) (Cafe-au-lait spot) and [HP:0001067](http://purl.obolibrary.org/obo/HP_0001067) (Neurofibromas) and [HP:0002858](http://purl.obolibrary.org/obo/HP_0002858) (Meningioma) 64.71%
- [HP:0001067](http://purl.obolibrary.org/obo/HP_0001067) (Neurofibromas) and [HP:0011355](http://purl.obolibrary.org/obo/HP_0011355) (Localized skin lesion) and [HP:0012374](http://purl.obolibrary.org/obo/HP_0012374) (Abnormality of the globe) and [HP:0100835](http://purl.obolibrary.org/obo/HP_0100835) (Benign neoplasm of the central nervous system) 64.71%
- [HP:0001067](http://purl.obolibrary.org/obo/HP_0001067) (Neurofibromas) and [HP:0011355](http://purl.obolibrary.org/obo/HP_0011355) (Localized skin lesion) and [HP:0012372](http://purl.obolibrary.org/obo/HP_0012372) (Abnormal eye morphology) and [HP:0100835](http://purl.obolibrary.org/obo/HP_0100835) (Benign neoplasm of the central nervous system) 64.71%
- [HP:0001067](http://purl.obolibrary.org/obo/HP_0001067) (Neurofibromas) and [HP:0011121](http://purl.obolibrary.org/obo/HP_0011121) (Abnormality of skin morphology) and [HP:0012374](http://purl.obolibrary.org/obo/HP_0012374) (Abnormality of the globe) and [HP:0100835](http://purl.obolibrary.org/obo/HP_0100835) (Benign neoplasm of the central nervous system) 64.71%
- [HP:0001067](http://purl.obolibrary.org/obo/HP_0001067) (Neurofibromas) and [HP:0011121](http://purl.obolibrary.org/obo/HP_0011121) (Abnormality of skin morphology) and [HP:0012372](http://purl.obolibrary.org/obo/HP_0012372) (Abnormal eye morphology) and [HP:0100835](http://purl.obolibrary.org/obo/HP_0100835) (Benign neoplasm of the central nervous system) 64.71%
- [HP:0001067](http://purl.obolibrary.org/obo/HP_0001067) (Neurofibromas) and [HP:0004328](http://purl.obolibrary.org/obo/HP_0004328) (Abnormality of the anterior segment of the globe) and [HP:0011355](http://purl.obolibrary.org/obo/HP_0011355) (Localized skin lesion) and [HP:0100835](http://purl.obolibrary.org/obo/HP_0100835) (Benign neoplasm of the central nervous system) 64.71%
- [HP:0001067](http://purl.obolibrary.org/obo/HP_0001067) (Neurofibromas) and [HP:0004328](http://purl.obolibrary.org/obo/HP_0004328) (Abnormality of the anterior segment of the globe) and [HP:0011121](http://purl.obolibrary.org/obo/HP_0011121) (Abnormality of skin morphology) and [HP:0100835](http://purl.obolibrary.org/obo/HP_0100835) (Benign neoplasm of the central nervous system) 64.71%
- [HP:0001067](http://purl.obolibrary.org/obo/HP_0001067) (Neurofibromas) and [HP:0002858](http://purl.obolibrary.org/obo/HP_0002858) (Meningioma) and [HP:0011355](http://purl.obolibrary.org/obo/HP_0011355) (Localized skin lesion) and [HP:0012374](http://purl.obolibrary.org/obo/HP_0012374) (Abnormality of the globe) 64.71%
- [HP:0001067](http://purl.obolibrary.org/obo/HP_0001067) (Neurofibromas) and [HP:0002858](http://purl.obolibrary.org/obo/HP_0002858) (Meningioma) and [HP:0011355](http://purl.obolibrary.org/obo/HP_0011355) (Localized skin lesion) and [HP:0012372](http://purl.obolibrary.org/obo/HP_0012372) (Abnormal eye morphology) 64.71%
- [HP:0001067](http://purl.obolibrary.org/obo/HP_0001067) (Neurofibromas) and [HP:0002858](http://purl.obolibrary.org/obo/HP_0002858) (Meningioma) and [HP:0011121](http://purl.obolibrary.org/obo/HP_0011121) (Abnormality of skin morphology) and [HP:0012374](http://purl.obolibrary.org/obo/HP_0012374) (Abnormality of the globe) 64.71%
- [HP:0001067](http://purl.obolibrary.org/obo/HP_0001067) (Neurofibromas) and [HP:0002858](http://purl.obolibrary.org/obo/HP_0002858) (Meningioma) and [HP:0011121](http://purl.obolibrary.org/obo/HP_0011121) (Abnormality of skin morphology) and [HP:0012372](http://purl.obolibrary.org/obo/HP_0012372) (Abnormal eye morphology) 64.71%
- [HP:0001067](http://purl.obolibrary.org/obo/HP_0001067) (Neurofibromas) and [HP:0002858](http://purl.obolibrary.org/obo/HP_0002858) (Meningioma) and [HP:0004328](http://purl.obolibrary.org/obo/HP_0004328) (Abnormality of the anterior segment of the globe) and [HP:0011355](http://purl.obolibrary.org/obo/HP_0011355) (Localized skin lesion) 64.71%


